Login / Signup

Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT.

Yongqiong DengHong ZhaoJiyuan ZhouLinlin YanGui-Qiang Wangnull null
Published in: BMC infectious diseases (2017)
The complete clinical trials protocol is available by request at clinicaltrials.gov ( NCT01962155 ) and chictr.org ( ChiCTR-DDT-13003724 ).
Keyphrases
  • liver fibrosis
  • clinical trial
  • randomized controlled trial
  • phase ii
  • open label
  • hepatitis b virus
  • study protocol
  • double blind